Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
1 result for Superlist ID equals I910000000
Drug Name: Ixmyelocel-T
Description: Manufacturers Statement: Ixmyelocel-T is a patient-specific, expanded multicellular therapy, manufactured using Vericels proprietary, highly automated, fully closed cell-processing system. Vericels patent-protected technology selectively expands mesenchymal cells, monocytes and alternatively activated macrophages, up to several hundred times more than the number found in the patients bone marrow, while retaining many of the hematopoietic cells collected from only a small sample (50ml) of the patients bone marrow.  

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: May 2020